KRT38

gene
On this page

Summary

KRT38 (keratin 38, HGNC:6456) is a protein-coding gene on chromosome 17q21.2, encoding Keratin, type I cuticular Ha8 (O76015).

The protein encoded by this gene is a member of the keratin gene family. As a type I hair keratin, it is an acidic protein which heterodimerizes with type II keratins to form hair and nails. The type I hair keratins are clustered in a region of chromosome 17q12-q21 and have the same direction of transcription.

Source: NCBI Gene 8687 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 85 total
  • MANE Select transcript: NM_006771

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:6456
Approved symbolKRT38
Namekeratin 38
Location17q21.2
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000171360
Ensembl biotypeprotein_coding
OMIM604542
Entrez8687

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000246646

RefSeq mRNA: 1 — MANE Select: NM_006771 NM_006771

CCDS: CCDS11392

Canonical transcript exons

ENST00000246646 — 7 exons

ExonStartEnd
ENSE000012500514143615441437541
ENSE000023366074143920341439359
ENSE000023696564144043041440983
ENSE000023793724143809341438313
ENSE000023901604144016141440243
ENSE000023986164143849141438616
ENSE000024188834143869741438858

Expression profiles

Bgee: expression breadth broad, 24 present calls, max score 73.26.

Top tissues by expression

266 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
tibialis anteriorUBERON:000138573.26silver quality
ileal mucosaUBERON:000033164.98silver quality
hair follicleUBERON:000207360.03silver quality
upper leg skinUBERON:000426259.61silver quality
deltoidUBERON:000147657.71gold quality
skin of hipUBERON:000155457.29silver quality
deciduaUBERON:000245056.55gold quality
pancreatic ductal cellCL:000207955.65silver quality
epithelial cell of pancreasCL:000008350.44gold quality
quadriceps femorisUBERON:000137750.06gold quality
Brodmann (1909) area 46UBERON:000648349.30gold quality
blood vessel layerUBERON:000479749.29gold quality
cervix squamous epitheliumUBERON:000692249.20gold quality
olfactory bulbUBERON:000226448.92gold quality
choroid plexus epitheliumUBERON:000391148.89gold quality
myocardiumUBERON:000234948.87gold quality
type B pancreatic cellCL:000016948.83gold quality
cardiac muscle of right atriumUBERON:000337948.55gold quality
CA1 field of hippocampusUBERON:000388148.50gold quality
vastus lateralisUBERON:000137948.25gold quality
left ventricle myocardiumUBERON:000656648.24gold quality
orbitofrontal cortexUBERON:000416748.20gold quality
upper arm skinUBERON:000426348.06gold quality
cervix epitheliumUBERON:000480148.04gold quality
oviduct epitheliumUBERON:000480448.00gold quality
tongue squamous epitheliumUBERON:000691947.92gold quality
mucosa of urinary bladderUBERON:000125947.80gold quality
nasal cavity epitheliumUBERON:000538447.70gold quality
thymusUBERON:000237047.42gold quality
periodontal ligamentUBERON:000826647.14gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.47

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

58 targeting KRT38, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4476100.0068.182030
HSA-MIR-6876-5P100.0067.682126
HSA-MIR-6873-3P100.0071.422626
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-4650-5P99.9864.69999
HSA-MIR-6508-5P99.9270.672465
HSA-MIR-129799.9173.413162
HSA-MIR-806799.8669.592260
HSA-MIR-607999.8468.541170
HSA-MIR-4760-5P99.8069.881619
HSA-MIR-4766-5P99.7569.232662
HSA-MIR-548M99.7068.871749
HSA-MIR-472999.6972.184233
HSA-MIR-519A-3P99.6771.671868
HSA-MIR-519B-3P99.6771.671868
HSA-MIR-519C-3P99.6771.671870
HSA-MIR-806199.6369.441411
HSA-MIR-6832-5P99.5864.821132
HSA-MIR-3616-5P99.5567.02989
HSA-MIR-57399.5567.44955
HSA-MIR-451B99.5568.281380
HSA-MIR-671-5P99.5267.111277
HSA-MIR-312399.4767.152693
HSA-MIR-616599.4467.121389
HSA-MIR-513A-3P99.3970.633620
HSA-MIR-513C-3P99.3970.633620
HSA-MIR-4786-3P99.3668.351390
HSA-MIR-751599.3168.221795
HSA-MIR-6828-5P99.3169.211433
HSA-MIR-3925-5P99.2167.901466

Cross-species orthologs

0 orthologs

Paralogs (68): KRT33A (ENSG00000006059), VIM (ENSG00000026025), KRT31 (ENSG00000094796), NEFM (ENSG00000104722), KRT23 (ENSG00000108244), KRT37 (ENSG00000108417), KRT32 (ENSG00000108759), KRT18 (ENSG00000111057), LMNB1 (ENSG00000113368), KRT36 (ENSG00000126337), KRT17 (ENSG00000128422), GFAP (ENSG00000131095), KRT34 (ENSG00000131737), KRT33B (ENSG00000131738), NES (ENSG00000132688), PRPH (ENSG00000135406), KRT85 (ENSG00000135443), KRT7 (ENSG00000135480), KRT71 (ENSG00000139648), INA (ENSG00000148798), LMNTD1 (ENSG00000152936), LMNA (ENSG00000160789), KRT84 (ENSG00000161849), KRT82 (ENSG00000161850), KRT80 (ENSG00000167767), KRT1 (ENSG00000167768), KRT24 (ENSG00000167916), KRT8 (ENSG00000170421), KRT78 (ENSG00000170423), KRT86 (ENSG00000170442), KRT75 (ENSG00000170454), KRT6C (ENSG00000170465), KRT4 (ENSG00000170477), KRT74 (ENSG00000170484), KRT72 (ENSG00000170486), KRT83 (ENSG00000170523), BFSP2 (ENSG00000170819), KRT19 (ENSG00000171345), KRT15 (ENSG00000171346), KRT13 (ENSG00000171401)

Protein

Protein identifiers

Keratin, type I cuticular Ha8O76015 (reviewed: O76015)

Alternative names: Hair keratin, type I Ha8, Keratin-38

All UniProt accessions (1): O76015

UniProt curated annotations — full annotation on UniProt →

Miscellaneous. There are two types of hair/microfibrillar keratin, I (acidic) and II (neutral to basic).

Similarity. Belongs to the intermediate filament family.

RefSeq proteins (1): NP_006762* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002957Keratin_IFamily
IPR018039IF_conservedConserved_site
IPR039008IF_rod_domDomain

Pfam: PF00038

UniProt features (12 total): region of interest 7, chain 1, domain 1, sequence variant 1, sequence conflict 1, site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O76015-F175.920.54

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (1): 353 (stutter)

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-6805567Keratinization
R-HSA-6809371Formation of the cornified envelope
R-HSA-1266738Developmental Biology

MSigDB gene sets: 44 (showing top): GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM, GOBP_EPITHELIUM_DEVELOPMENT, GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS, GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION, JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP, TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA, GOBP_TISSUE_MORPHOGENESIS, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_KERATIN_FILAMENT, CAMPS_COLON_CANCER_COPY_NUMBER_UP, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, MARTENS_TRETINOIN_RESPONSE_UP, GOBP_SUPRAMOLECULAR_FIBER_ORGANIZATION, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER

GO Biological Process (3): morphogenesis of an epithelium (GO:0002009), epithelial cell differentiation (GO:0030855), intermediate filament organization (GO:0045109)

GO Molecular Function (3): structural molecule activity (GO:0005198), structural constituent of skin epidermis (GO:0030280), protein binding (GO:0005515)

GO Cellular Component (5): cytosol (GO:0005829), cytoskeleton (GO:0005856), keratin filament (GO:0045095), extracellular exosome (GO:0070062), intermediate filament (GO:0005882)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Developmental Biology1
Keratinization1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
epithelium development2
tissue morphogenesis1
cell differentiation1
intermediate filament cytoskeleton organization1
supramolecular fiber organization1
molecular_function1
structural molecule activity1
binding1
cytoplasm1
cellular anatomical structure1
intracellular membraneless organelle1
intermediate filament1
extracellular vesicle1
intermediate filament cytoskeleton1
polymeric cytoskeletal fiber1

Protein interactions and networks

STRING

476 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
KRT38KRTAP11-1Q8IUC1521
KRT38KRTAP3-1Q9BYR8520
KRT38KRTAP15-1Q3LI76490
KRT38KRTAP10-9P60411481
KRT38KRTAP10-3P60369449
KRT38KRTAP10-4P60372448
KRT38KRTAP13-1Q8IUC0446
KRT38KRTAP10-11P60412437
KRT38KRTAP10-5P60370402
KRT38ZNF714Q96N38398
KRT38KRTAP10-7P60409396
KRT38PABIR3Q6P4D5390
KRT38KRTDAPP60985383
KRT38KRTAP10-8P60410382
KRT38KRTAP7-1Q8IUC3381

IntAct

350 interactions, top by confidence:

ABTypeScore
KRT6AKRT38psi-mi:“MI:0915”(physical association)0.890
KRT38KRT6Apsi-mi:“MI:0915”(physical association)0.890
KRT38KRT2psi-mi:“MI:0915”(physical association)0.840
KRT2KRT38psi-mi:“MI:0915”(physical association)0.840
KRT38KRT4psi-mi:“MI:0915”(physical association)0.830
TXLNBKRT38psi-mi:“MI:0915”(physical association)0.830
KRT38SCNM1psi-mi:“MI:0915”(physical association)0.830
KRT4KRT38psi-mi:“MI:0915”(physical association)0.830
SCNM1KRT38psi-mi:“MI:0915”(physical association)0.830

BioGRID (224): KRT38 (Two-hybrid), KRT38 (Two-hybrid), KRT38 (Two-hybrid), KRT38 (Two-hybrid), KRT38 (Two-hybrid), KRT38 (Two-hybrid), KRT38 (Two-hybrid), KRT38 (Two-hybrid), KRT38 (Two-hybrid), KRT38 (Two-hybrid), KRT38 (Two-hybrid), KRT38 (Two-hybrid), KRT38 (Two-hybrid), KRT38 (Two-hybrid), KRT38 (Two-hybrid)

ESM2 similar proteins: A0JND2, A3KN27, A6BLY7, A6H712, A6QNX5, A6QQJ3, A7YWK3, D3ZER2, E1AB55, O76014, O76015, P08552, P15331, P21807, P35617, P41219, P46660, P48670, Q0VBK2, Q13515, Q148H5, Q148H6, Q148H8, Q14CN4, Q28177, Q3SY84, Q3TRJ4, Q6A162, Q6IFW3, Q6IFW8, Q6IFX0, Q6IFX4, Q6IFZ9, Q6IG04, Q6IME9, Q6IMF1, Q6KB66, Q6NVD9, Q6NXH9, Q7RTS7

Diamond homologs: A1L317, A1L595, A5A6M0, A5A6M5, A5A6N2, A5A6P3, A6BLY7, A6H712, A6QQQ9, A7YWM2, B0LKP1, B1AQ75, O18740, O57611, O76009, O76011, O76013, O76015, O77727, O93256, P02533, P02534, P02535, P02537, P05781, P06394, P08727, P08728, P08730, P08777, P08778, P08779, P13645, P13646, P19001, P19012, P25030, P25690, P35527, P35900

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 46 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Formation of the cornified envelope1130.2×7e-12
Keratinization1119.1×5e-10

GO biological processes:

GO termPartnersFoldFDR
intermediate filament organization1063.4×5e-14
keratinization1061.6×5e-14

Disease & clinical

Clinical variants and AI predictions

ClinVar

85 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance74
Likely benign8
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

515 predictions. Top by Δscore:

VariantEffectΔscore
17:41438086:CACGT:Cdonor_loss1.0000
17:41438087:ACGT:Adonor_loss1.0000
17:41438088:CGTAC:Cdonor_loss1.0000
17:41438089:GTA:Gdonor_loss1.0000
17:41438090:T:TGdonor_loss1.0000
17:41438091:A:ACdonor_gain1.0000
17:41438091:A:ATdonor_loss1.0000
17:41438092:C:CGdonor_gain1.0000
17:41438092:CTTG:Cdonor_gain1.0000
17:41438095:G:Adonor_gain1.0000
17:41438099:T:TAdonor_gain1.0000
17:41438108:T:Adonor_gain1.0000
17:41438309:TCCTT:Tacceptor_gain1.0000
17:41438310:CCTTC:Cacceptor_gain1.0000
17:41438311:CTT:Cacceptor_gain1.0000
17:41438312:TT:Tacceptor_gain1.0000
17:41438313:TC:Tacceptor_loss1.0000
17:41438314:C:CCacceptor_gain1.0000
17:41438315:T:Cacceptor_loss1.0000
17:41438316:G:Cacceptor_gain1.0000
17:41438316:G:GCacceptor_gain1.0000
17:41438319:G:Cacceptor_gain1.0000
17:41438319:G:GCacceptor_gain1.0000
17:41438326:A:ACacceptor_gain1.0000
17:41438326:A:Cacceptor_gain1.0000
17:41438487:GTAC:Gdonor_loss1.0000
17:41438488:TA:Tdonor_loss1.0000
17:41438489:A:ACdonor_gain1.0000
17:41438489:AC:Adonor_gain1.0000
17:41438489:ACCAA:Adonor_loss1.0000

AlphaMissense

2988 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:41440581:C:GR114P0.990
17:41438195:A:GL380P0.982
17:41438189:C:GR382P0.980
17:41438114:A:GL407P0.979
17:41438144:A:GL397P0.979
17:41440576:C:GA116P0.979
17:41438120:C:GR405P0.978
17:41438204:C:GR377P0.977
17:41438216:A:GL373P0.977
17:41438186:T:GQ383P0.975
17:41440578:A:GL115P0.975
17:41438165:A:GL390P0.972
17:41438124:A:GY404H0.970
17:41440548:A:GL125P0.967
17:41440566:A:GL119P0.967
17:41440578:A:TL115Q0.965
17:41438132:A:CI401S0.963
17:41440554:C:GR123P0.962
17:41438152:C:AK394N0.961
17:41438152:C:GK394N0.961
17:41438124:A:CY404D0.958
17:41440582:G:TR114S0.958
17:41440587:T:AN112I0.958
17:41438135:T:AE400V0.956
17:41438202:C:GA378P0.955
17:41440590:A:GL111P0.955
17:41438162:A:GL391P0.949
17:41440192:C:GA182P0.949
17:41438147:C:GR396P0.943
17:41438175:A:CY387D0.942

dbSNP variants (sampled 300 via entrez): RS1000143898 (17:41437632 A>G), RS1001820607 (17:41441598 A>C,G), RS1002011815 (17:41440180 C>T), RS1002068367 (17:41441304 C>T), RS1002126661 (17:41442708 A>G), RS1002539244 (17:41437356 A>G), RS1004180826 (17:41442680 G>T), RS1004594981 (17:41436691 A>C,G), RS1005295927 (17:41435789 T>C), RS1006715257 (17:41437983 G>T), RS1006935776 (17:41439139 G>A,T), RS1008314925 (17:41441729 G>A), RS1008341668 (17:41442049 C>A,T), RS1008370915 (17:41436372 A>G), RS1008403481 (17:41436699 T>C)

Disease associations

OMIM: gene MIM:604542 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneincreases methylation, increases mutagenesis2
CGP 52608affects binding, increases reaction1
Air Pollutantsincreases expression1
Arsenicaffects methylation1
Atrazineincreases expression1
Folic Aciddecreases expression1
Valproic Acidincreases methylation1
Sodium Selenitedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.